BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20331535)

  • 1. Top-up transfusions in neonates with Rh hemolytic disease in relation to exchange transfusions.
    Rath ME; Smits-Wintjens VE; Lindenburg I; Brand A; Oepkes D; Walther FJ; Lopriore E
    Vox Sang; 2010 Jul; 99(1):65-70. PubMed ID: 20331535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postnatal outcome in neonates with severe Rhesus c compared to rhesus D hemolytic disease.
    Rath ME; Smits-Wintjens VE; Lindenburg IT; Folman CC; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
    Transfusion; 2013 Jul; 53(7):1580-5. PubMed ID: 23113703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion.
    De Boer IP; Zeestraten EC; Lopriore E; van Kamp IL; Kanhai HH; Walther FJ
    Am J Obstet Gynecol; 2008 Jan; 198(1):54.e1-4. PubMed ID: 18166305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exchange transfusions and top-up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease.
    Rath ME; Smits-Wintjens VE; Lindenburg IT; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
    Vox Sang; 2011 Apr; 100(3):312-6. PubMed ID: 20849463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biochemical and hematometric effects of exchange transfusion in isoimmunized neonates].
    Jurfest-Ceccon ME; de Albuquerque Diniz EM; de Araujo-Ramos JL; Costa-Vaz FA
    Bol Med Hosp Infant Mex; 1993 Mar; 50(3):167-76. PubMed ID: 8442881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hemolytic disease of the newborn due to anti-Cw.
    Byers BD; Gordon MC; Higby K
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1180-2. PubMed ID: 16260563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-stage single-volume exchange transfusion in severe hemolytic disease of the newborn.
    Abbas W; Attia NI; Hassanein SM
    J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1080-3. PubMed ID: 21919551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current validity of the exchange transfusion intervention by the classic indication. Our 15 years' experience].
    Zuppa AA; Vento G; Tornesello A; Papacci P; Micanti M; Coviello C; Palusci A; Mazzotta M; Fundarò C; Romagnoli C
    Minerva Pediatr; 1990 Apr; 42(4):135-41. PubMed ID: 2115969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease.
    Smits-Wintjens VE; Rath ME; van Zwet EW; Oepkes D; Brand A; Walther FJ; Lopriore E
    Neonatology; 2013; 103(2):141-7. PubMed ID: 23235106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High dosage immunoglobulin therapy in Rhesus incompatibility].
    Hofstadler G; Hohenauer L
    Klin Padiatr; 1995; 207(3):103-5. PubMed ID: 7623424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Term neonates with hemolytic disease of the newborn and necrotizing enterocolitis: a report of two cases.
    Roig JC; Burchfield DJ
    J Perinatol; 1994; 14(3):201-3. PubMed ID: 8064424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modification of coagulation factors during neonatal exchange transfusions].
    Spears R; Couchard M; Relier JP; Jensen AH; Pinon F; Sender P
    Ann Pediatr (Paris); 1976 Oct; 23(10):611-6. PubMed ID: 16106888
    [No Abstract]   [Full Text] [Related]  

  • 14. Late hyporegenerative anemia in neonates with rhesus hemolytic disease.
    al-Alaiyan S; al Omran A
    J Perinat Med; 1999; 27(2):112-5. PubMed ID: 10379500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal outcome after fetal anemia managed by intrauterine transfusion.
    Garabedian C; Rakza T; Thomas D; Wibaut B; Vaast P; Subtil D; Houfflin-Debarge V
    Eur J Pediatr; 2015 Nov; 174(11):1535-9. PubMed ID: 26032762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advantages of larger volume, less frequent intrauterine red blood cell transfusions for maternal red cell alloimmunization.
    Inglis SR; Lysikiewicz A; Sonnenblick AL; Streltzoff JL; Bussel JB; Chervenak FA
    Am J Perinatol; 1996 Jan; 13(1):27-33. PubMed ID: 8645382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin to treat neonatal alloimmune haemolytic disease.
    Corvaglia L; Legnani E; Galletti S; Arcuri S; Aceti A; Faldella G
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2782-5. PubMed ID: 22882154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Spectrophotometric characteristics of the amniotic fluid in Rh isoimmunization following intrauterine fetal blood transfusions].
    Matrova TS; Vasileva Iu
    Akush Ginekol (Sofiia); 1989; 28(1):30-2. PubMed ID: 2500862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced techniques for the treatment of severe isoimmunization.
    Vomund SL; Witter SE
    MCN Am J Matern Child Nurs; 1994; 19(1):18-23. PubMed ID: 8201857
    [No Abstract]   [Full Text] [Related]  

  • 20. Whole blood versus red cells and plasma for exchange transfusion in ABO haemolytic disease.
    Yigit S; Gursoy T; Kanra T; Aydin M; Erdem G; Tekinalp G; Yurdakok M
    Transfus Med; 2005 Aug; 15(4):313-8. PubMed ID: 16101809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.